T cell receptor alpha joining 39 (TRAJ39)

TRAJ39 encodes a joining (J) segment of the alpha chain of the T cell receptor (TCR). In T cells, the diversity of the TCR repertoire is generated by the somatic recombination of various V (variable), J (joining), and C (constant) gene segments, including TRAJ39. This recombination produces the highly variable antigen recognition sites of individual T cells, enabling precise recognition of a vast array of peptide-MHC complexes and underpinning adaptive immunity. TRAJ39 is not itself a receptor, enzyme, transporter, or transcription factor, and it is not a direct therapeutic target; rather, it is a genetic segment necessary for the generation of antigen-specific T cell receptors. There are no known drugs directly targeting TRAJ39, and it is not used as a standalone biomarker or considered a therapeutic target. Dysfunction or genetic variation in joining segments like TRAJ39 would impact the diversity of the TCR repertoire but has not been directly linked to specific diseases or targeted clinically. If your focus is on the T cell receptor alpha chain as a whole, that entity would be considered a "Receptor" and a valid immunotherapeutic target; however, TRAJ39 refers specifically to a gene segment within the TCR alpha locus, not the complete receptor complex.

Other names

TRAJ39